Booth D R, Gillmore J D, Booth S E, Pepys M B, Hawkins P N
Immunological Medicine Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
QJM. 1998 Sep;91(9):603-6. doi: 10.1093/qjmed/91.9.603.
Familial Mediterranean fever (FMF) is an inherited inflammatory disease that is frequently complicated by reactive systemic (AA) amyloidosis. It is principally recognized in certain Mediterranean populations, and the diagnosis depends on clinical features. Four mutations strongly linked to FMF have lately been identified in a gene encoding a novel protein that has been named pyrin or marenostrin. We studied 27 consecutive patients of varied ethnic origin, including an English man, who had classical, probable or possible FMF. Pyrin/marenostrin genotypes were determined, and AA amyloidosis was sought using serum amyloid P component scintigraphy. Among the 23 patients with classical or probable FMF, 17 were homozygotes or compound heterozygotes for pyrin/marenostrin mutations, and in five, only single allele mutations were identified. Two new mutations, T6811 and delta M694, were discovered in addition to the four described previously. No mutations were identified in three of the four patients with possible FMF. Nine patients had AA amyloidosis, but this association was not restricted to any particular genotype. Most patients with FMF have mutations in both pyrin/marenostrin alleles, and genotyping at this locus is a valuable diagnostic test. Unidentified second mutations are likely to occur in FMF patients who have apparently solitary mutations, and therefore genotype results must be interpreted in conjunction with the clinical picture.
家族性地中海热(FMF)是一种遗传性炎症性疾病,常并发反应性全身性(AA)淀粉样变性。该病主要在某些地中海人群中被认识,其诊断依赖于临床特征。最近在一个编码一种名为吡啉或marenostrin的新型蛋白质的基因中,发现了四个与FMF密切相关的突变。我们研究了27例连续的不同种族患者,包括一名英国男性,他们患有典型、可能或疑似FMF。确定了吡啉/marenostrin基因型,并使用血清淀粉样蛋白P成分闪烁扫描法寻找AA淀粉样变性。在23例患有典型或可能FMF的患者中,17例为吡啉/marenostrin突变的纯合子或复合杂合子,5例仅鉴定出单等位基因突变。除了先前描述的四个突变外,还发现了两个新突变,T6811和δM694。在4例疑似FMF的患者中,有3例未发现突变。9例患者患有AA淀粉样变性,但这种关联并不局限于任何特定基因型。大多数FMF患者的吡啉/marenostrin两个等位基因都有突变,在这个位点进行基因分型是一项有价值的诊断测试。在明显只有单个突变的FMF患者中,可能会出现未鉴定的第二个突变,因此基因型结果必须结合临床情况进行解释。